These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 35163607)

  • 1. Nanoparticles in Clinical Translation for Cancer Therapy.
    Mundekkad D; Cho WC
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
    Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
    Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodrugs as a New Approach in the Therapy of Cardiovascular Diseases and Cancer with Tumor-associated Angiogenesis.
    Hajtuch J; Niska K; Inkielewicz-Stepniak I
    Curr Med Chem; 2021; 28(27):5527-5550. PubMed ID: 33390102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation.
    Gonzalez-Valdivieso J; Girotti A; Schneider J; Arias FJ
    Int J Pharm; 2021 Apr; 599():120438. PubMed ID: 33662472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
    Babu A; Templeton AK; Munshi A; Ramesh R
    AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and challenges in the translation of cancer nanomedicines.
    Tong F; Wang Y; Gao H
    Curr Opin Biotechnol; 2024 Feb; 85():103045. PubMed ID: 38096768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting nanoparticles to malignant tumors.
    Sharma N; Bietar K; Stochaj U
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188703. PubMed ID: 35227830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures.
    Saravanakumar K; Anbazhagan S; Pujani Usliyanage J; Vishven Naveen K; Wijesinghe U; Xiaowen H; Vishnu Priya V; Thiripuranathar G; Wang MH
    Int Immunopharmacol; 2022 Feb; 103():108433. PubMed ID: 34922248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for Cancer Targeting: Current and Future Directions.
    Swain S; Sahu PK; Beg S; Babu SM
    Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing cells to deliver nanoparticle drugs to treat cancer.
    Singh B; Mitragotri S
    Biotechnol Adv; 2020; 42():107339. PubMed ID: 30639928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].
    Alexiou C; Tietze R; Schreiber E; Lyer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):839-45. PubMed ID: 20700784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.
    Mu Q; Yu J; McConnachie LA; Kraft JC; Gao Y; Gulati GK; Ho RJY
    J Drug Target; 2018; 26(5-6):435-447. PubMed ID: 29285948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.